DeepMed Research

University of Kansas Medical Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1906-01-01

Employees: 5K

Market Cap: -

Website: https://www.kumc.edu

Clinical Trials

Hyperpolarized 129Xe MRI Lung Health Cohort

Recruiting

Conditions: Healthy

First Posted Date: 2023-03-13

Last Posted Date: 2025-04-02

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 260

Registration Number: NCT05766384

Locations: 🇺🇸
University of Illinois-Chicago, Chicago, Illinois, United States
🇺🇸
University of Iowa, Iowa City, Iowa, United States
🇺🇸
Duke University, Durham, North Carolina, United States

and more 3 locations

Improving Smoking Abstinence Outcomes in the African American Community Through Extended Treatment

Phase 3

Recruiting

Conditions: Smoking Cessation

Interventions: Drug: Bupropion

First Posted Date: 2023-02-17

Last Posted Date: 2025-03-10

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 500

Registration Number: NCT05732272

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Missouri, United States

vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC

Not Applicable

Recruiting

Conditions: Liver Cancer

Interventions: Radiation: Stereotactic Body Radiation Treatment

First Posted Date: 2023-02-14

Last Posted Date: 2025-04-04

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 18

Registration Number: NCT05727787

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Rural Engagement in TelemedTeam for Options in Obesity Treatment Solutions

Not Applicable

Active, not recruiting

Conditions: Obesity
Obesity, Morbid

Interventions: Behavioral: Local Care + Model
Behavioral: Team Care Model

First Posted Date: 2023-02-02

Last Posted Date: 2025-05-11

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 560

Registration Number: NCT05710510

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Missouri, United States

Switching to E-cigarettes in African-American Smokers

Phase 3

Recruiting

Conditions: Smoking Reduction

Interventions: Other: Electronic cigarette
Drug: Placebo
Drug: Varenicline Tartrate

First Posted Date: 2023-01-30

Last Posted Date: 2024-12-20

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 500

Registration Number: NCT05703672

Locations: 🇺🇸
Swope Health Central, Kansas City, Missouri, United States
🇺🇸
University of Kansas Medical Center, Kansas City, Missouri, United States

Comparative Analysis of Spinal Anesthesia Versus General Anesthesia for vNOTES

Not Applicable

Conditions: Anesthesia
Tubal Ligation

Interventions: Procedure: General Anesthesia
Procedure: Spinal Anesthesia

First Posted Date: 2023-01-18

Last Posted Date: 2024-06-25

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 40

Registration Number: NCT05688943

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Pilot of Osanetant to Reduce Severity of Hot Flashes in Men With Adenocarcinoma of the Prostate

Early Phase 1

Withdrawn

Conditions: Prostate Adenocarcinoma

Interventions: Drug: Osanetant

First Posted Date: 2022-12-12

Last Posted Date: 2024-02-21

Lead Sponsor: University of Kansas Medical Center

Registration Number: NCT05647447

Locations: 🇺🇸
The University of Kansas Cancer Center, Westwood Campus, Kansas City, Kansas, United States

Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC

Phase 2

Recruiting

Conditions: Triple Negative Breast Cancer
Breast Cancer

Interventions: Drug: Carboplatin
Drug: Docetaxel
Drug: Pembrolizumab
Drug: Doxorubicin
Drug: Cyclophosphamide

First Posted Date: 2022-12-09

Last Posted Date: 2024-08-26

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 139

Registration Number: NCT05645380

Locations: 🇺🇸
The University of Kansas Cancer Center - Clinical Research Center, Fairway, Kansas, United States
🇺🇸
The University of Kansas Cancer Center - Main Hospital, Kansas City, Kansas, United States
🇺🇸
The University of Kansas Cancer Center - Westwood, Kansas City, Kansas, United States

and more 4 locations

Tg01 Vaccine / Qs-21 Stimulon™ With Or Without Balstilimab As Maintenance Therapy Following Adjuvant Chemotherapy In Patients With Resected Pancreatic Cancer

Phase 2

Recruiting

Conditions: Pancreas Cancer

Interventions: Biological: TG01 Vaccine
Drug: QS-21
Drug: Balstilimab

First Posted Date: 2022-12-06

Last Posted Date: 2023-01-31

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 24

Registration Number: NCT05638698

Locations: 🇺🇸
University of Kansas Cancer Center - Clinical Research Center, Fairway, Kansas, United States
🇺🇸
University of Kansas Cancer Center - Overland Park, Overland Park, Kansas, United States
🇺🇸
University of Kansas Cancer Center - Westwood, Westwood, Kansas, United States

and more 2 locations

iAmHealthy Parents First: A Televideo Parent and Child Obesity Program for Rural Families

Not Applicable

Recruiting

Conditions: Weight Loss
Pediatric Obesity

Interventions: Behavioral: iAmHealthy Parents First
Behavioral: iAmHealthy

First Posted Date: 2022-11-14

Last Posted Date: 2024-12-27

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 480

Registration Number: NCT05612971

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy